Curtis Sprouse: A Breakthrough Is Not a Business Plan

A brilliant invention can exist before anyone has answered the most important question: who needs it, and why? Curtis Sprouse joins CJ Moneyway for a conversation linking team behavior with biomedical innovation. Curtis is CEO and president of EurekaConnect, a company focused on leadership and team development. He is also involved with the Institute for Biomedical Entrepreneurship, which works to help researchers understand the path from scientific discovery to product opportunity. Curtis begins with his roots around Pittsburgh. He recalls the role sports played in learning to be part of a team and describes how his mother helped him seek an early dyslexia diagnosis. He is careful to distinguish the experience of dyslexia from the personal drive that made him competitive. The combination shaped how he thinks about challenges, relationships and the people who help someone develop. He tells CJ that good leadership increasingly means teaching other people how to think through a problem. A leader who supplies every answer becomes the limit of the organization. A leader who helps teammates define challenges, prepare for them and solve them can build greater capability around the mission. Their conversation then moves to the gap between scientific possibility and useful application. Curtis describes helping researchers identify their best role in a company. A talented chemist may remain the scientific lead while other people take responsibility for financing, operations or the commercial pathway. This is not a judgment about the scientist’s worth. It is a decision about how a team makes the work stronger. A meeting with a medical leader gives the discussion its sharpest test. By Curtis’s account, an outside expert challenged the proposed use of a technology his team was developing. Rather than treating the criticism as the end, Curtis describes the need to identify a clearer use case and put evidence behind it. The moment illustrates a distinction that applies well beyond biotech: the ability to build something does not yet establish that people need it. Curtis also explains his company’s use of behavioral assessments to discuss interpersonal strengths, openness and collaboration. These methods and the claims attached to them are Curtis’s account and should be evaluated on their own evidence. The episode’s larger question remains human: can a confident leader stay open to information that changes the plan? Join CJ and Curtis for a grounded conversation about people, scientific translation and leadership with enough integrity to change course. Topics covered • Pittsburgh, dyslexia and the value of early support. • From competitive athlete to leader who elevates others. • Connection and trust in professional relationships. • Why scientific expertise and company leadership can require different people. • An expert’s difficult question that changed a technology plan.  EurekaConnect: https://eurekaconnect.com/company • Institute for Biomedical Entrepreneurship: https://ibeinc.org/company • The CJ Moneyway Show: https://cjmoneyway.com • Podcast platforms: https://pod.link/1707761906 Curtis Sprouse, CJ Moneyway Show, EurekaConnect, Institute for Biomedical Entrepreneurship, biotech entrepreneurship, biomedical commercialization, bench to bedside, leadership development, scientist founder, product market need, use case validation, team behavior, dyslexia leadership, innovation and integrity, science to marketplace, founder role clarity Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.